US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anaptysbio Inc

19.29

+0.32001.69%

Post-market: 18.93-0.3600-1.87%19:42 EDT

Volume:870.03K

Turnover:16.48M

Market Cap:591.56M

PE:-3.77

High:19.42

Open:17.67

Low:17.67

Close:18.97

Loading ...

Overview Company News Filings

AnaptysBio Stock Down as Eczema Study Fails to Meet Goals

AnaptysBio price target lowered to $36 from $90 at Guggenheim

AnaptysBio Inc : H.c. Wainwright Cuts to Neutral Rating; Cuts Target Price to $19 From $52

THOMSON REUTERS

AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data

AnaptysBio (ANAB) Receives a Buy from TD Cowen

AnaptysBio Cut to Neutral From Buy by HC Wainwright & Co.

HC Wainwright Downgrades AnaptysBio to Neutral From Buy, $19 Price Target

MT Newswires Live

AnaptysBio downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright downgrades AnaptysBio after atopic dermatitis study disappoints

BUZZ-AnaptysBio slumps after abandoning eczema drug development

AnaptysBio Inc : Wedbush Cuts Target Price to $40 From $42

THOMSON REUTERS

UPDATE 2-AnaptysBio to abandon eczema drug development after mid-stage trial failure

Wedbush Cuts Price Target on AnaptysBio to $40 From $42, Maintains Outperform Rating

MT Newswires Live

Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year?

AnaptysBio to Drop Eczema Drug Candidate After Trials Miss Endpoints; Shares Fall

AnaptysBio Shares Fall 37.9% Premarket as Co Abandons Eczema Drug Development After Mid-Stage Trial Failure

THOMSON REUTERS

AnaptysBio Says Phase 2B Trial in Atopic Dermatitis Failed to Meet Endpoints

MT Newswires Live

BRIEF-Anaptys Announces Phase 2B Trial Of ANB032, A BTLA Agonist, Did Not Meet Endpoints

AnaptysBio abandons eczema drug development after mid-stage trial failure

AnaptysBio announces Phase 2b trial of ANB032 did not meet primary endpoint

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANAB/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANAB\",,,,,undefined,":{"symbol":"ANAB","market":"US","secType":"STK","nameCN":"Anaptysbio Inc","latestPrice":19.29,"timestamp":1743710400000,"preClose":18.97,"halted":0,"volume":870030,"hourTrading":{"tag":"盘后","latestPrice":18.93,"preClose":19.29,"latestTime":"19:42 EDT","volume":11233,"amount":216624.956469,"timestamp":1743723756325},"delay":0,"floatShares":18032376,"shares":30666781,"eps":-5.11701,"marketStatus":"Closed","change":0.32,"latestTime":"04-03 16:00:00 EDT","open":17.67,"high":19.42,"low":17.67,"amount":16477298.0631,"amplitude":0.092251,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.11701,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743753600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1485406800000,"exchange":"NASDAQ","adjPreClose":18.97,"preHourTrading":{"tag":"盘前","latestPrice":17.89,"preClose":18.97,"latestTime":"04:10 EDT","volume":1,"amount":17.89,"timestamp":1743667813964},"postHourTrading":{"tag":"盘后","latestPrice":18.93,"preClose":19.29,"latestTime":"19:42 EDT","volume":11233,"amount":216624.956469,"timestamp":1743723756325},"volumeRatio":1.033871,"impliedVol":1.4007,"impliedVolPercentile":0.7809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANAB\",,,,,undefined,":{"symbol":"ANAB","floatShares":18032376,"roa":"-15.35%","roe":"-182.71%","lyrEps":-5.11701,"volumeRatio":1.033871,"shares":30666781,"dividePrice":0,"high":19.42,"amplitude":0.092251,"preClose":18.97,"low":17.67,"week52Low":12.21,"pbRate":"8.35","psRate":"6.48","week52High":41.3083,"institutionHeld":0,"latestPrice":19.29,"eps":-5.11701,"divideRate":0,"volume":870030,"delay":0,"ttmEps":-5.11701,"open":17.67,"prevYearClose":13.24,"prevWeekClose":18.95,"prevMonthClose":18.59,"prevQuarterClose":18.59,"fiveDayClose":18.65,"twentyDayClose":16.4,"sixtyDayClose":15.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANAB\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490338665","title":"AnaptysBio Stock Down as Eczema Study Fails to Meet Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2490338665","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490338665?lang=en_us&edition=fundamental","pubTime":"2024-12-12 22:04","pubTimestamp":1734012240,"startTime":"0","endTime":"0","summary":"Shares of AnaptysBio, Inc. ANAB, a clinical-stage biotechnology company, plunged 32.8% on Dec. 11 after it announced that the phase IIb study of pipeline candidate, ANB032, a BTLA agonist, was unsuccessful.Consequently, ANAB discontinued any further investment in this asset.AnaptysBio has lost 27.6% so far this year compared with the industry’s decline of 8.1%.The ARISE-AD study evaluated the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of ANB032 monotherapy in patients with moderate-to-severe atopic dermatitis  or eczema.However, ANB032 did not meet the primary endpoint of the proportion of patients who achieved at least a 75% improvement from baseline in Eczema Area and Severity Index score , irrespective of the patient type.Other antibodies in its portfolio include ANB033, an anti-CD122 antagonist, in a phase I study and ANB101, a BDCA2 modulator, soon to enter clinical development.Anaptys also has an immuno-oncology collaboration with GSK plc GSK. It discov","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anaptysbio-stock-down-eczema-study-140400245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1829250122.USD","BK4196","ANAB","BK4585","GSK","IMCR","BK4007","BK4532","CSTL","BK4505","BK4139","GSK.UK","BK4588"],"gpt_icon":0},{"id":"2490243807","title":"AnaptysBio price target lowered to $36 from $90 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2490243807","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490243807?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:36","pubTimestamp":1734006962,"startTime":"0","endTime":"0","summary":"Guggenheim lowered the firm’s price target on AnaptysBio (ANAB) to $36 from $90 and keeps a Buy rating on the shares following the announcement tha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anaptysbio-price-target-lowered-to-36-from-90-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anaptysbio-price-target-lowered-to-36-from-90-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490734878","title":"AnaptysBio Inc : H.c. Wainwright Cuts to Neutral Rating; Cuts Target Price to $19 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2490734878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490734878?lang=en_us&edition=fundamental","pubTime":"2024-12-12 15:34","pubTimestamp":1733988875,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nFWN3ND0C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490892906","title":"AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2490892906","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490892906?lang=en_us&edition=fundamental","pubTime":"2024-12-12 03:07","pubTimestamp":1733944049,"startTime":"0","endTime":"0","summary":"On Wednesday, AnaptysBio, Inc.  announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary endpoints in any of the doses studied in the ARISE-AD trial as a monotherapy for moderate-to-severe atopic dermatitis  or eczema.“While ANB032 was safe and well tolerated, we’re disappointed by these efficacy results in AD and will discontinue further investment in this asset. Moving forward, our resources and capital will be focused on the rest of our exciting autoimmune portfolio,” said Daniel Faga, president and chief executive officer of Anaptys.Also Read: AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly’s: Analyst. “We look forward to sharing for rosnilimab, a depleter and agonist targeting PD-1+ T cells, top-line Phase 2b rheumatoid arthritis data in February 2025 and top-line Phase 2 ulcerative colitis data in Q1 2026, followed by Phase 1b data from our two additional programs.”","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/z41yvmmdPcImOoa8u7EAeA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/5c6adf7f2436195f59d33e6ca9bf8e50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/z41yvmmdPcImOoa8u7EAeA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/5c6adf7f2436195f59d33e6ca9bf8e50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anaptysbio-discontinues-investment-eczema-candidate-190729599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490037896","title":"AnaptysBio (ANAB) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2490037896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490037896?lang=en_us&edition=fundamental","pubTime":"2024-12-12 02:25","pubTimestamp":1733941506,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Joseph Thome maintained a Buy rating on AnaptysBio (ANAB – Research Report) today. The company’s shares opened today at $14.32. Ac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/anaptysbio-anab-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/anaptysbio-anab-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","TD","BK4139","COWN","BK4127","BK4207","BK4585","ANAB"],"gpt_icon":0},{"id":"2490895868","title":"AnaptysBio Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2490895868","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490895868?lang=en_us&edition=fundamental","pubTime":"2024-12-12 01:54","pubTimestamp":1733939640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANAB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2024 12:54 ET (17:54 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB"],"gpt_icon":0},{"id":"2490789334","title":"HC Wainwright Downgrades AnaptysBio to Neutral From Buy, $19 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2490789334","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490789334?lang=en_us&edition=fundamental","pubTime":"2024-12-12 01:33","pubTimestamp":1733938439,"startTime":"0","endTime":"0","summary":"Price: 14.92, Change: -8.17, Percent Change: -35.38","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANAB"],"gpt_icon":0},{"id":"2490893362","title":"AnaptysBio downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2490893362","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490893362?lang=en_us&edition=fundamental","pubTime":"2024-12-12 01:25","pubTimestamp":1733937923,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar downgraded AnaptysBio (ANAB) to Neutral from Buy with a $19 price target Published first on TheFly – the ultim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anaptysbio-downgraded-to-neutral-from-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anaptysbio-downgraded-to-neutral-from-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490893355","title":"H.C. Wainwright downgrades AnaptysBio after atopic dermatitis study disappoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2490893355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490893355?lang=en_us&edition=fundamental","pubTime":"2024-12-12 01:25","pubTimestamp":1733937910,"startTime":"0","endTime":"0","summary":"H.C. Wainwright downgraded AnaptysBio (ANAB) to Neutral from Buy with a price target of $19, down from $52, after the company announced topline res...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-downgrades-anaptysbio-after-atopic-dermatitis-study-disappoints?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-downgrades-anaptysbio-after-atopic-dermatitis-study-disappoints?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490886298","title":"BUZZ-AnaptysBio slumps after abandoning eczema drug development","url":"https://stock-news.laohu8.com/highlight/detail?id=2490886298","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490886298?lang=en_us&edition=fundamental","pubTime":"2024-12-12 00:20","pubTimestamp":1733934053,"startTime":"0","endTime":"0","summary":"BUZZ-AnaptysBio slumps after abandoning eczema drug development ** Shares of AnaptysBio ANAB.O fall as much as 38.5% to an over one-year low of $14.20 ** Stock set for worst day since Nov 2019, if losses hold** Co says it will discontinue development of its eczema drug ANB032 after it failed to meet the goals of a mid-stage trial** Drug did not meet the main goal of a proportion of patients achieving an at least 75% improvement of symptoms on an eczema severity index** ANAB will focus on the rest of its autoimmune portfolio, which includes drugs for rheumatoid arthritis and a type of inflammatory bowel disease - CEO** Up to last close, stock down 30.6% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4N3NC1B3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490686639","title":"AnaptysBio Inc : Wedbush Cuts Target Price to $40 From $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2490686639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490686639?lang=en_us&edition=fundamental","pubTime":"2024-12-11 23:17","pubTimestamp":1733930258,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC18B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490865022","title":"UPDATE 2-AnaptysBio to abandon eczema drug development after mid-stage trial failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2490865022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490865022?lang=en_us&edition=fundamental","pubTime":"2024-12-11 23:14","pubTimestamp":1733930098,"startTime":"0","endTime":"0","summary":"(Updates shares in paragraph 1, adds details on disease and background in paragraphs 4-6)      Dec 11 (Reuters) - AnaptysBio    will end the development of its experimental drug to treat eczema as the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490865928","title":"Wedbush Cuts Price Target on AnaptysBio to $40 From $42, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2490865928","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490865928?lang=en_us&edition=fundamental","pubTime":"2024-12-11 23:05","pubTimestamp":1733929501,"startTime":"0","endTime":"0","summary":"AnaptysBio (ANAB) has an average rating of overweight and mean price target of $55.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANAB"],"gpt_icon":0},{"id":"2490862692","title":"Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490862692","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490862692?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:40","pubTimestamp":1733928010,"startTime":"0","endTime":"0","summary":"Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Siga Technologies Inc.  is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Siga Technologies Inc. is one of 1022 individual stocks in the Medical sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Siga Technologies Inc. ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kz0ozt3ejWMPXKci2JxOBw--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kz0ozt3ejWMPXKci2JxOBw--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/siga-technologies-siga-stock-outpacing-144010372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","ANAB","SIGA","BK4007","BK4139"],"gpt_icon":0},{"id":"2490868260","title":"AnaptysBio to Drop Eczema Drug Candidate After Trials Miss Endpoints; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868260","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490868260?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:36","pubTimestamp":1733927760,"startTime":"0","endTime":"0","summary":"AnaptysBio shares plummeted in premarket trading Wednesday after the company said it will discontinue its dermatitis treatment after the drug failed to meet its targets in recent trials.Shares fell over 39% to $14 ahead of the morning bell.The clinical-stage biotechnology company said its investigational drug ANB032 didn't meet either primary or secondary endpoints in its 201-patient Arise-AD trial as a therapy for atopic dermatitis, often referred to as eczema.Atopic dermatitis is a chronic disease that causes inflammation and irritation of the skin, often beginning at a young age.\"While ANB032 was safe and well tolerated, we're disappointed by these efficacy results in AD and will discontinue further investment in this asset,\" Chief Executive Daniel Faga said.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"AnaptysBio to Drop Eczema Drug Candidate After Trials Miss Endpoints; Shares Fall","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490500648","title":"AnaptysBio Shares Fall 37.9% Premarket as Co Abandons Eczema Drug Development After Mid-Stage Trial Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2490500648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490500648?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:25","pubTimestamp":1733927147,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490857719","title":"AnaptysBio Says Phase 2B Trial in Atopic Dermatitis Failed to Meet Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2490857719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490857719?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:57","pubTimestamp":1733925464,"startTime":"0","endTime":"0","summary":"AnaptysBio  said Wednesday that it would discontinue further investment in experimental therapy ANB032 after a phase 2b trial in moderate-to-severe atopic dermatitis or eczema did not meet the primary and secondary endpoints.The company said it would focus its resources and capital on its other investigational autoimmune drugs.AnaptysBio said it expects to report top-line phase 2b data for rosnilimab in rheumatoid arthritis in February and top-line phase 2 data in ulcerative colitis in Q1 of 2026.Shares of the company were up more than 2% in recent premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490520658","title":"BRIEF-Anaptys Announces Phase 2B Trial Of ANB032, A BTLA Agonist, Did Not Meet Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2490520658","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490520658?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:44","pubTimestamp":1733924678,"startTime":"0","endTime":"0","summary":"BRIEF-Anaptys Announces Phase 2B Trial Of ANB032, A BTLA Agonist, Did Not Meet Endpoints Dec 11 (Reuters) - AnaptysBio ANAB.O:ANAPTYS ANNOUNCES PHASE 2B TRIAL OF ANB032, A BTLA AGONIST, DID NOT MEET P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nTUA5K6FK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490526508","title":"AnaptysBio abandons eczema drug development after mid-stage trial failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2490526508","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490526508?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:36","pubTimestamp":1733924171,"startTime":"0","endTime":"0","summary":"AnaptysBio abandons eczema drug development after mid-stage trial failureDec 11  - AnaptysBio ANAB.O said on Wednesday that it would discontinue the development of its eczema drug after it failed to meet the main and secondary goals of a mid-stage trial.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4N3NC0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490984852","title":"AnaptysBio announces Phase 2b trial of ANB032 did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2490984852","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490984852?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:35","pubTimestamp":1733924136,"startTime":"0","endTime":"0","summary":"AnaptysBio (ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary endpoints in any of the doses studi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anaptysbio-announces-phase-2b-trial-of-anb032-did-not-meet-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anaptysbio-announces-phase-2b-trial-of-anb032-did-not-meet-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ANAB"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":127}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"ANAB","fiscalQuarterEnding":"2024/12","expectedEps":-1.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.72},{"market":"US","date":"2024-11-05","symbol":"ANAB","fiscalQuarterEnding":"2024/09","expectedEps":-1.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2024-08-05","symbol":"ANAB","fiscalQuarterEnding":"2024/06","expectedEps":-1.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":-1.71},{"market":"US","date":"2024-05-09","symbol":"ANAB","fiscalQuarterEnding":"2024/03","expectedEps":-1.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-1.64},{"market":"US","date":"2024-03-11","symbol":"ANAB","fiscalQuarterEnding":"2023/12","expectedEps":-1.74,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710129600000,"reportTimeType":"post","actualEps":-1.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANAB","date":"2025-04-02","current":-3.885319,"percent":0.731747,"low":-107.113838,"twenty":-9.868611,"median":-5.68837,"eighty":-3.60191,"high":122.514739,"avg":-4.0465,"sd":35.046773,"marketCap":564268770},"quantilePoints":[{"date":"2020-04-03","current":-3.94962,"twenty":-104.43711,"median":-48.481987,"eighty":-16.803394,"marketCap":384440194},{"date":"2020-04-09","current":-4.282957,"twenty":-104.075772,"median":-48.229,"eighty":-15.617973,"marketCap":416885855},{"date":"2020-04-17","current":-4.756351,"twenty":-103.898188,"median":-47.768723,"eighty":-14.877,"marketCap":462964148},{"date":"2020-04-24","current":-4.529458,"twenty":-103.521035,"median":-47.717023,"eighty":-14.540754,"marketCap":440879286},{"date":"2020-05-01","current":-4.282016,"twenty":-102.360822,"median":-47.630719,"eighty":-14.279153,"marketCap":416794317},{"date":"2020-05-08","current":-5.963603,"twenty":-102.21688,"median":-47.27063,"eighty":-13.927156,"marketCap":498080119},{"date":"2020-05-15","current":-6.146495,"twenty":-101.627764,"median":-47.210801,"eighty":-13.673774,"marketCap":513355304},{"date":"2020-05-22","current":-6.489419,"twenty":-101.315349,"median":-46.829498,"eighty":-13.329309,"marketCap":541996275},{"date":"2020-05-29","current":-6.23141,"twenty":-101.145154,"median":-46.635721,"eighty":-13.216999,"marketCap":520447354},{"date":"2020-06-05","current":-6.348984,"twenty":-100.994275,"median":-46.353129,"eighty":-12.915679,"marketCap":530267115},{"date":"2020-06-12","current":-6.051783,"twenty":-98.863273,"median":-46.2545,"eighty":-12.812956,"marketCap":505444940},{"date":"2020-06-19","current":-7.299372,"twenty":-97.282542,"median":-46.094759,"eighty":-12.682841,"marketCap":609643520},{"date":"2020-06-26","current":-7.394084,"twenty":-97.172002,"median":-45.973649,"eighty":-12.319887,"marketCap":617553883},{"date":"2020-07-02","current":-7.361424,"twenty":-97.09082,"median":-45.865995,"eighty":-11.997337,"marketCap":614826172},{"date":"2020-07-10","current":-6.936853,"twenty":-97.060378,"median":-44.893241,"eighty":-11.604251,"marketCap":579365922},{"date":"2020-07-17","current":-7.165468,"twenty":-96.641788,"median":-44.6818,"eighty":-11.333063,"marketCap":598459903},{"date":"2020-07-24","current":-6.329388,"twenty":-96.23563,"median":-44.446908,"eighty":-7.578936,"marketCap":528630488},{"date":"2020-07-31","current":-5.865625,"twenty":-96.022508,"median":-44.084321,"eighty":-7.405188,"marketCap":489896985},{"date":"2020-08-07","current":-6.028922,"twenty":-95.657006,"median":-43.867463,"eighty":-7.356853,"marketCap":503535542},{"date":"2020-08-14","current":-5.692594,"twenty":-95.382396,"median":-42.906555,"eighty":-7.249729,"marketCap":461703554},{"date":"2020-08-21","current":-5.877747,"twenty":-95.112918,"median":-41.814068,"eighty":-7.011969,"marketCap":476720524},{"date":"2020-08-28","current":-5.699327,"twenty":-95.051072,"median":-39.751195,"eighty":-6.757879,"marketCap":462249626},{"date":"2020-09-04","current":-5.372786,"twenty":-94.731497,"median":-38.336331,"eighty":-6.608299,"marketCap":435765152},{"date":"2020-09-11","current":-4.861092,"twenty":-94.485965,"median":-38.193546,"eighty":-6.504443,"marketCap":394263709},{"date":"2020-09-18","current":-5.413183,"twenty":-94.353581,"median":-37.928746,"eighty":-6.445002,"marketCap":439041582},{"date":"2020-09-25","current":-4.914954,"twenty":-94.257075,"median":-37.663945,"eighty":-6.339839,"marketCap":398632282},{"date":"2020-10-02","current":-5.254961,"twenty":-94.147431,"median":-37.419914,"eighty":-6.285625,"marketCap":426208899},{"date":"2020-10-09","current":-5.669029,"twenty":-93.735088,"median":-37.248573,"eighty":-6.226184,"marketCap":459792304},{"date":"2020-10-16","current":-8.106308,"twenty":-93.464568,"median":-37.17069,"eighty":-6.218346,"marketCap":657470230},{"date":"2020-10-23","current":-8.661765,"twenty":-93.420761,"median":-36.981177,"eighty":-6.226184,"marketCap":702521139},{"date":"2020-10-30","current":-9.917435,"twenty":-93.389294,"median":-36.765701,"eighty":-6.258844,"marketCap":804363496},{"date":"2020-11-06","current":-10.703569,"twenty":-93.320185,"median":-36.625513,"eighty":-6.279093,"marketCap":790351564},{"date":"2020-11-13","current":-10.833197,"twenty":-93.225065,"median":-36.407442,"eighty":-6.282359,"marketCap":799923296},{"date":"2020-11-20","current":-9.799877,"twenty":-93.102802,"median":-36.282831,"eighty":-6.285625,"marketCap":723622920},{"date":"2020-11-27","current":-9.551732,"twenty":-92.960679,"median":-36.101104,"eighty":-6.301301,"marketCap":705299890},{"date":"2020-12-04","current":-8.948036,"twenty":-92.81426,"median":-36.038799,"eighty":-6.325469,"marketCap":660722968},{"date":"2020-12-11","current":-8.503597,"twenty":-92.686841,"median":-35.89861,"eighty":-6.332001,"marketCap":627905602},{"date":"2020-12-18","current":-8.444338,"twenty":-92.396892,"median":-35.768806,"eighty":-6.338533,"marketCap":623529954},{"date":"2020-12-24","current":-8.240637,"twenty":-92.182886,"median":-35.701308,"eighty":-6.343758,"marketCap":608488661},{"date":"2020-12-31","current":-7.962863,"twenty":-92.182886,"median":-35.545543,"eighty":-6.348984,"marketCap":587977807},{"date":"2021-01-08","current":-9.385067,"twenty":-92.14863,"median":-35.379395,"eighty":-6.375111,"marketCap":692993378},{"date":"2021-01-15","current":-9.670249,"twenty":-91.985291,"median":-35.202861,"eighty":-6.417568,"marketCap":714051188},{"date":"2021-01-22","current":-9.459141,"twenty":-91.677485,"median":-35.031519,"eighty":-6.454146,"marketCap":698462939},{"date":"2021-01-29","current":-9.59988,"twenty":-91.490915,"median":-34.996265,"eighty":-6.484193,"marketCap":708855105},{"date":"2021-02-05","current":-10.818383,"twenty":-91.299081,"median":-34.753062,"eighty":-6.494645,"marketCap":798829384},{"date":"2021-02-12","current":-13.047984,"twenty":-90.952994,"median":-34.388024,"eighty":-6.501177,"marketCap":963463170},{"date":"2021-02-19","current":-10.803568,"twenty":-90.787654,"median":-34.236956,"eighty":-6.504443,"marketCap":797735471},{"date":"2021-02-26","current":-39.391762,"twenty":-90.593908,"median":-34.17968,"eighty":-6.552778,"marketCap":785117200},{"date":"2021-03-05","current":-40.448614,"twenty":-90.442681,"median":-34.388024,"eighty":-6.586091,"marketCap":806181320},{"date":"2021-03-12","current":-29.303628,"twenty":-90.369262,"median":-34.17968,"eighty":-6.603074,"marketCap":584050600},{"date":"2021-03-19","current":-29.536959,"twenty":-90.271614,"median":-33.938275,"eighty":-6.631161,"marketCap":588701120},{"date":"2021-03-26","current":-29.111473,"twenty":-90.167815,"median":-33.911537,"eighty":-6.668392,"marketCap":580220760},{"date":"2021-04-01","current":-29.907543,"twenty":-90.10307,"median":-33.764632,"eighty":-6.704971,"marketCap":596087240},{"date":"2021-04-09","current":-28.644811,"twenty":-90.056712,"median":-33.686999,"eighty":-6.746122,"marketCap":570919720},{"date":"2021-04-16","current":-29.811466,"twenty":-90.014454,"median":-33.14234,"eighty":-6.787273,"marketCap":594172320},{"date":"2021-04-23","current":-32.405557,"twenty":-89.896866,"median":-33.041179,"eighty":-6.836475,"marketCap":645875160},{"date":"2021-04-30","current":-32.062001,"twenty":-89.76979,"median":-33.064374,"eighty":-6.889164,"marketCap":639027739},{"date":"2021-05-07","current":-24.000343,"twenty":-89.659439,"median":-32.847073,"eighty":-6.966899,"marketCap":715978245},{"date":"2021-05-14","current":-23.945297,"twenty":-89.433486,"median":-32.643367,"eighty":-7.011969,"marketCap":714336093},{"date":"2021-05-21","current":-23.275562,"twenty":-89.177361,"median":-32.526722,"eighty":-7.062918,"marketCap":694356578},{"date":"2021-05-28","current":-21.899396,"twenty":-89.117329,"median":-32.389503,"eighty":-7.149792,"marketCap":653302780},{"date":"2021-06-04","current":-20.917731,"twenty":-89.095065,"median":-32.165446,"eighty":-7.176572,"marketCap":624017737},{"date":"2021-06-11","current":-22.275548,"twenty":-88.971253,"median":-32.153771,"eighty":-7.228174,"marketCap":664524151},{"date":"2021-06-18","current":-22.32142,"twenty":-88.710958,"median":-32.066795,"eighty":-7.264752,"marketCap":665892611},{"date":"2021-06-25","current":-24.257228,"twenty":-88.62939,"median":-32.017847,"eighty":-7.296759,"marketCap":723641621},{"date":"2021-07-02","current":-23.706761,"twenty":-88.61741,"median":-31.951807,"eighty":-7.309823,"marketCap":707220102},{"date":"2021-07-09","current":-23.844378,"twenty":-88.596554,"median":-31.869492,"eighty":-7.351627,"marketCap":711325482},{"date":"2021-07-16","current":-23.917773,"twenty":-88.277702,"median":-31.584142,"eighty":-7.358159,"marketCap":713515017},{"date":"2021-07-23","current":-23.624191,"twenty":-88.225176,"median":-31.44408,"eighty":-7.361424,"marketCap":704756874},{"date":"2021-07-30","current":-21.082871,"twenty":-88.03791,"median":-31.365362,"eighty":-7.385897,"marketCap":628944193},{"date":"2021-08-06","current":-21.541593,"twenty":-87.661094,"median":-31.129099,"eighty":-7.394084,"marketCap":642628792},{"date":"2021-08-13","current":-74.211439,"twenty":-87.540211,"median":-31.365362,"eighty":-7.39735,"marketCap":646604271},{"date":"2021-08-20","current":-76.289486,"twenty":-87.471939,"median":-31.44408,"eighty":-7.407148,"marketCap":664710288},{"date":"2021-08-27","current":-79.815867,"twenty":-87.455558,"median":-31.584142,"eighty":-7.433275,"marketCap":695435650},{"date":"2021-09-03","current":-84.381272,"twenty":-87.202721,"median":-31.869492,"eighty":-7.514924,"marketCap":735214021},{"date":"2021-09-10","current":-81.264202,"twenty":-87.130943,"median":-31.951807,"eighty":-7.5306,"marketCap":708054995},{"date":"2021-09-17","current":-84.759098,"twenty":-87.082688,"median":-32.017847,"eighty":-7.578936,"marketCap":738506024},{"date":"2021-09-24","current":-86.081491,"twenty":-87.130943,"median":-32.066795,"eighty":-7.788609,"marketCap":750028035},{"date":"2021-10-01","current":-86.86863,"twenty":-87.082688,"median":-32.153771,"eighty":-7.937941,"marketCap":756886374},{"date":"2021-10-08","current":-88.253994,"twenty":-87.130943,"median":-32.165446,"eighty":-7.989529,"marketCap":768957052},{"date":"2021-10-15","current":-90.269069,"twenty":-87.485593,"median":-32.39753,"eighty":-8.034714,"marketCap":786514402},{"date":"2021-10-22","current":-89.891243,"twenty":-87.736457,"median":-32.53832,"eighty":-8.09175,"marketCap":783222399},{"date":"2021-10-29","current":-103.587457,"twenty":-88.310743,"median":-32.676995,"eighty":-8.105767,"marketCap":902557511},{"date":"2021-11-05","current":121.206519,"twenty":-88.498825,"median":-32.710623,"eighty":-8.09175,"marketCap":1016680284},{"date":"2021-11-12","current":107.401579,"twenty":-88.449205,"median":-32.590843,"eighty":-7.788609,"marketCap":900884445},{"date":"2021-11-19","current":101.006676,"twenty":-88.310743,"median":-32.405557,"eighty":-7.42805,"marketCap":847243997},{"date":"2021-11-26","current":102.056096,"twenty":-88.263477,"median":-32.300442,"eighty":-7.390809,"marketCap":856046532},{"date":"2021-12-03","current":99.039013,"twenty":-88.236703,"median":-32.158148,"eighty":-7.330725,"marketCap":830739244},{"date":"2021-12-10","current":98.383126,"twenty":-88.112816,"median":-32.108332,"eighty":-7.198781,"marketCap":825237660},{"date":"2021-12-17","current":116.616799,"twenty":-87.81182,"median":-32.063805,"eighty":-6.981923,"marketCap":978181706},{"date":"2021-12-23","current":121.568749,"twenty":-87.64637,"median":-31.965725,"eighty":-6.787273,"marketCap":1019718668},{"date":"2021-12-31","current":114.527209,"twenty":-87.590654,"median":-31.886153,"eighty":-6.625282,"marketCap":960654228},{"date":"2022-01-07","current":107.968672,"twenty":-87.512902,"median":-31.744362,"eighty":-6.503789,"marketCap":905641223},{"date":"2022-01-14","current":111.198504,"twenty":-87.465387,"median":-31.474719,"eighty":-6.435857,"marketCap":932733055},{"date":"2022-01-21","current":102.1352,"twenty":-87.404991,"median":-31.433351,"eighty":-6.343758,"marketCap":856710058},{"date":"2022-01-28","current":103.090967,"twenty":-87.082688,"median":-31.139961,"eighty":-6.286278,"marketCap":864727029},{"date":"2022-02-04","current":103.387584,"twenty":-86.659797,"median":-30.807233,"eighty":-6.218346,"marketCap":867215054},{"date":"2022-02-11","current":98.839453,"twenty":-86.123364,"median":-30.46627,"eighty":-6.096853,"marketCap":829065332},{"date":"2022-02-18","current":98.872411,"twenty":-85.686428,"median":-30.19227,"eighty":-6.039372,"marketCap":829341780},{"date":"2022-02-25","current":103.585329,"twenty":-85.389506,"median":-29.908779,"eighty":-5.981432,"marketCap":868873738},{"date":"2022-03-04","current":99.696347,"twenty":-85.044783,"median":-29.616083,"eighty":-5.941808,"marketCap":836252961},{"date":"2022-03-11","current":-13.694174,"twenty":-84.849106,"median":-29.457961,"eighty":-5.941808,"marketCap":791468505},{"date":"2022-03-18","current":-13.171647,"twenty":-84.179764,"median":-29.293712,"eighty":-5.941808,"marketCap":761268494},{"date":"2022-03-25","current":-12.099146,"twenty":-83.207815,"median":-29.117087,"eighty":-5.941808,"marketCap":699282255},{"date":"2022-04-01","current":-11.993811,"twenty":-82.693975,"median":-28.864249,"eighty":-5.941808,"marketCap":693194321},{"date":"2022-04-08","current":-12.558789,"twenty":-82.218961,"median":-28.602291,"eighty":-5.941808,"marketCap":725847786},{"date":"2022-04-14","current":-10.945251,"twenty":-81.834485,"median":-28.440131,"eighty":-5.941808,"marketCap":632591704},{"date":"2022-04-22","current":-10.586154,"twenty":-81.257019,"median":-28.16628,"eighty":-5.941808,"marketCap":611837383},{"date":"2022-04-29","current":-11.2038,"twenty":-79.985253,"median":-27.857252,"eighty":-5.941808,"marketCap":647534815},{"date":"2022-05-06","current":-8.266576,"twenty":-79.076657,"median":-27.557745,"eighty":-5.941808,"marketCap":627333942},{"date":"2022-05-13","current":-7.848033,"twenty":-78.070148,"median":-27.087535,"eighty":-5.941808,"marketCap":595571553},{"date":"2022-05-20","current":-7.755179,"twenty":-76.645664,"median":-26.326588,"eighty":-5.941808,"marketCap":588525037},{"date":"2022-05-27","current":-7.298337,"twenty":-75.64915,"median":-24.101263,"eighty":-5.941808,"marketCap":553856177},{"date":"2022-06-03","current":-7.784892,"twenty":-74.999024,"median":-23.94071,"eighty":-5.941808,"marketCap":590779922},{"date":"2022-06-10","current":-8.171166,"twenty":-74.630316,"median":-23.844378,"eighty":-5.941808,"marketCap":620093430},{"date":"2022-06-17","current":-7.966887,"twenty":-74.313821,"median":-23.729697,"eighty":-5.941808,"marketCap":604591094},{"date":"2022-06-24","current":-8.587152,"twenty":-73.79367,"median":-23.624191,"eighty":-5.940942,"marketCap":651661822},{"date":"2022-07-01","current":-7.602898,"twenty":-73.236005,"median":-23.475818,"eighty":-5.940942,"marketCap":576968750},{"date":"2022-07-08","current":-7.547186,"twenty":-72.726873,"median":-23.119597,"eighty":-5.940942,"marketCap":572740840},{"date":"2022-07-15","current":-7.554614,"twenty":-72.028355,"median":-22.871887,"eighty":-5.940942,"marketCap":573304562},{"date":"2022-07-22","current":-7.781178,"twenty":-70.850347,"median":-22.48656,"eighty":-5.940942,"marketCap":590498061},{"date":"2022-07-29","current":-7.777464,"twenty":-69.195237,"median":-22.32142,"eighty":-5.940942,"marketCap":590216201},{"date":"2022-08-05","current":-9.170277,"twenty":-62.556885,"median":-22.15628,"eighty":-5.940942,"marketCap":695913944},{"date":"2022-08-12","current":-6.844736,"twenty":-62.060745,"median":-22.027838,"eighty":-5.940942,"marketCap":739320484},{"date":"2022-08-19","current":-6.5962,"twenty":-59.317433,"median":-21.945268,"eighty":-5.940942,"marketCap":712475318},{"date":"2022-08-26","current":-6.170048,"twenty":-57.318145,"median":-21.761779,"eighty":-5.940942,"marketCap":666445403},{"date":"2022-09-02","current":-6.494237,"twenty":-56.475572,"median":-21.611737,"eighty":-5.940942,"marketCap":701462026},{"date":"2022-09-09","current":-6.713849,"twenty":-55.356675,"median":-21.541593,"eighty":-5.940942,"marketCap":725182964},{"date":"2022-09-16","current":-6.606657,"twenty":-54.652593,"median":-21.477894,"eighty":-5.940942,"marketCap":713604887},{"date":"2022-09-23","current":-6.643259,"twenty":-53.92042,"median":-21.414909,"eighty":-5.940942,"marketCap":717558376},{"date":"2022-09-30","current":-6.669404,"twenty":-53.330905,"median":-21.182651,"eighty":-5.940942,"marketCap":720382298},{"date":"2022-10-07","current":-6.855028,"twenty":-52.739996,"median":-20.917731,"eighty":-5.940942,"marketCap":740432138},{"date":"2022-10-14","current":-6.933461,"twenty":-52.199259,"median":-20.253622,"eighty":-5.940942,"marketCap":748903902},{"date":"2022-10-21","current":-7.221048,"twenty":-51.254531,"median":-17.117041,"eighty":-5.940942,"marketCap":779967035},{"date":"2022-10-28","current":-7.55308,"twenty":-50.630173,"median":-15.497445,"eighty":-5.940942,"marketCap":815830834},{"date":"2022-11-04","current":-7.757005,"twenty":-49.841198,"median":-14.803867,"eighty":-5.940942,"marketCap":837857420},{"date":"2022-11-11","current":-6.529731,"twenty":-49.674799,"median":-14.446249,"eighty":-5.940942,"marketCap":880527643},{"date":"2022-11-18","current":-5.751729,"twenty":-49.04403,"median":-14.110688,"eighty":-5.923625,"marketCap":775614920},{"date":"2022-11-25","current":-5.93516,"twenty":-48.51213,"median":-13.957248,"eighty":-5.892149,"marketCap":800350440},{"date":"2022-12-02","current":-5.758054,"twenty":-47.764966,"median":-13.692948,"eighty":-5.859701,"marketCap":776467869},{"date":"2022-12-09","current":-5.903534,"twenty":-47.615808,"median":-13.340267,"eighty":-5.844082,"marketCap":796085696},{"date":"2022-12-16","current":-5.876125,"twenty":-47.20632,"median":-13.186182,"eighty":-5.844082,"marketCap":792389583},{"date":"2022-12-23","current":-6.162868,"twenty":-46.47424,"median":-12.915679,"eighty":-5.833129,"marketCap":831056603},{"date":"2022-12-30","current":-6.533947,"twenty":-46.256273,"median":-12.812956,"eighty":-5.833129,"marketCap":881096275},{"date":"2023-01-06","current":-4.897825,"twenty":-46.073767,"median":-12.768443,"eighty":-5.829319,"marketCap":660466811},{"date":"2023-01-13","current":-5.561973,"twenty":-44.92759,"median":-12.558789,"eighty":-5.783211,"marketCap":750026452},{"date":"2023-01-20","current":-5.271013,"twenty":-44.638657,"median":-12.412337,"eighty":-5.751729,"marketCap":710790800},{"date":"2023-01-27","current":-5.083365,"twenty":-44.055254,"median":-12.225773,"eighty":-5.700407,"marketCap":685486647},{"date":"2023-02-03","current":-5.435468,"twenty":-42.408992,"median":-12.066504,"eighty":-5.661805,"marketCap":732967472},{"date":"2023-02-10","current":-5.439685,"twenty":-40.030163,"median":-11.993811,"eighty":-5.565611,"marketCap":733536105},{"date":"2023-02-17","current":-5.690585,"twenty":-38.543535,"median":-11.845385,"eighty":-5.486597,"marketCap":767369747},{"date":"2023-02-24","current":-5.258362,"twenty":-38.190431,"median":-11.604251,"eighty":-5.471311,"marketCap":709084902},{"date":"2023-03-03","current":-5.170725,"twenty":-37.805597,"median":-11.538956,"eighty":-5.437998,"marketCap":665596397},{"date":"2023-03-10","current":-4.853929,"twenty":-37.307763,"median":-11.302931,"eighty":-5.396973,"marketCap":624817096},{"date":"2023-03-17","current":-4.730248,"twenty":-37.088654,"median":-11.014677,"eighty":-5.364706,"marketCap":608896410},{"date":"2023-03-24","current":-4.643454,"twenty":-36.653551,"median":-10.95619,"eighty":-5.306297,"marketCap":597723999},{"date":"2023-03-31","current":-4.721568,"twenty":-36.357597,"median":-10.831346,"eighty":-5.260049,"marketCap":607779169},{"date":"2023-04-06","current":-4.623926,"twenty":-36.091759,"median":-10.753708,"eighty":-5.249507,"marketCap":595210206},{"date":"2023-04-14","current":-4.730248,"twenty":-35.861227,"median":-10.6077,"eighty":-5.185412,"marketCap":608896410},{"date":"2023-04-21","current":-4.70125,"twenty":-35.63181,"median":-10.149873,"eighty":-5.136804,"marketCap":605163736},{"date":"2023-04-28","current":-4.352363,"twenty":-35.253744,"median":-9.9031,"eighty":-5.098389,"marketCap":560253557},{"date":"2023-05-05","current":-4.398309,"twenty":-35.013053,"median":-9.786914,"eighty":-4.983017,"marketCap":566167942},{"date":"2023-05-12","current":-4.081967,"twenty":-34.470661,"median":-9.603583,"eighty":-4.957371,"marketCap":558102871},{"date":"2023-05-19","current":-3.722141,"twenty":-34.090505,"median":-9.510991,"eighty":-4.897525,"marketCap":508905942},{"date":"2023-05-26","current":-3.611086,"twenty":-33.894489,"median":-9.360057,"eighty":-4.850845,"marketCap":493722153},{"date":"2023-06-02","current":-3.58009,"twenty":-33.688088,"median":-9.257292,"eighty":-4.819837,"marketCap":489484195},{"date":"2023-06-09","current":-3.549093,"twenty":-33.106266,"median":-9.148034,"eighty":-4.794041,"marketCap":485246236},{"date":"2023-06-16","current":-3.642083,"twenty":-32.766404,"median":-9.025813,"eighty":-4.756992,"marketCap":497960112},{"date":"2023-06-23","current":-3.880368,"twenty":-32.493211,"median":-8.918407,"eighty":-4.731128,"marketCap":530539417},{"date":"2023-06-30","current":-3.924925,"twenty":-32.161901,"median":-8.858113,"eighty":-4.721568,"marketCap":536631482},{"date":"2023-07-07","current":-3.901678,"twenty":-32.066795,"median":-8.722068,"eighty":-4.69336,"marketCap":533453013},{"date":"2023-07-14","current":-3.603337,"twenty":-31.951807,"median":-8.646655,"eighty":-4.671662,"marketCap":492662664},{"date":"2023-07-21","current":-3.6014,"twenty":-31.54475,"median":-8.552745,"eighty":-4.659575,"marketCap":492397791},{"date":"2023-07-28","current":-3.243003,"twenty":-31.321254,"median":-8.441462,"eighty":-4.623926,"marketCap":443396397},{"date":"2023-08-04","current":-3.702138,"twenty":-30.936353,"median":-8.351302,"eighty":-4.591378,"marketCap":506171156},{"date":"2023-08-11","current":-3.330754,"twenty":-30.573065,"median":-8.156309,"eighty":-4.57374,"marketCap":479678594},{"date":"2023-08-18","current":-3.548258,"twenty":-30.291853,"median":-8.104955,"eighty":-4.54306,"marketCap":511002376},{"date":"2023-08-25","current":-3.732583,"twenty":-29.910014,"median":-8.033302,"eighty":-4.501445,"marketCap":537547954},{"date":"2023-09-01","current":-3.627518,"twenty":-29.626581,"median":-7.964875,"eighty":-4.482485,"marketCap":522416975},{"date":"2023-09-08","current":-3.690188,"twenty":-29.516357,"median":-7.882544,"eighty":-4.473435,"marketCap":531442471},{"date":"2023-09-15","current":-3.625675,"twenty":-29.331339,"median":-7.801606,"eighty":-4.421911,"marketCap":522151519},{"date":"2023-09-22","current":-3.161175,"twenty":-29.15813,"median":-7.768178,"eighty":-4.410373,"marketCap":455256662},{"date":"2023-09-29","current":-3.317852,"twenty":-28.945556,"median":-7.725466,"eighty":-4.383798,"marketCap":477820404},{"date":"2023-10-06","current":-3.638577,"twenty":-28.662123,"median":-7.611562,"eighty":-4.375394,"marketCap":524009709},{"date":"2023-10-13","current":-3.422917,"twenty":-28.450396,"median":-7.556471,"eighty":-4.348186,"marketCap":492951383},{"date":"2023-10-20","current":-3.284673,"twenty":-28.181862,"median":-7.539758,"eighty":-4.312301,"marketCap":473042199},{"date":"2023-10-27","current":-3.12984,"twenty":-27.910364,"median":-7.514924,"eighty":-4.282957,"marketCap":450743914},{"date":"2023-11-03","current":-2.909183,"twenty":-27.625641,"median":-7.420904,"eighty":-4.264419,"marketCap":430038363},{"date":"2023-11-10","current":-2.680512,"twenty":-27.198159,"median":-7.391191,"eighty":-4.20096,"marketCap":396235903},{"date":"2023-11-17","current":-2.563655,"twenty":-26.430091,"median":-7.351627,"eighty":-4.109811,"marketCap":378962038},{"date":"2023-11-24","current":-2.569048,"twenty":-25.349793,"median":-7.298337,"eighty":-4.075111,"marketCap":379759293},{"date":"2023-12-01","current":-2.542081,"twenty":-23.954471,"median":-7.241963,"eighty":-4.038275,"marketCap":375773016},{"date":"2023-12-08","current":-2.951979,"twenty":-23.903095,"median":-7.172476,"eighty":-3.982656,"marketCap":436364422},{"date":"2023-12-14","current":-3.284571,"twenty":-23.833369,"median":-7.137386,"eighty":-3.970669,"marketCap":485528502},{"date":"2023-12-20","current":-3.597387,"twenty":-23.752633,"median":-7.120671,"eighty":-3.958023,"marketCap":531769311},{"date":"2023-12-27","current":-3.861663,"twenty":-23.624191,"median":-7.053202,"eighty":-3.944578,"marketCap":570834823},{"date":"2024-01-05","current":-3.890427,"twenty":-23.539787,"median":-7.011969,"eighty":-3.921497,"marketCap":575086851},{"date":"2024-01-12","current":-4.138523,"twenty":-23.15079,"median":-6.935157,"eighty":-3.919889,"marketCap":611760597},{"date":"2024-01-19","current":-4.258975,"twenty":-22.879227,"median":-6.855028,"eighty":-3.918726,"marketCap":629565966},{"date":"2024-01-26","current":-4.246391,"twenty":-22.543442,"median":-6.828329,"eighty":-3.919889,"marketCap":627705704},{"date":"2024-02-02","current":-4.359652,"twenty":-22.369757,"median":-6.766255,"eighty":-3.919889,"marketCap":644448066},{"date":"2024-02-09","current":-4.158299,"twenty":-22.174383,"median":-6.716463,"eighty":-3.919889,"marketCap":614683867},{"date":"2024-02-16","current":-4.09178,"twenty":-22.048022,"median":-6.682618,"eighty":-3.919889,"marketCap":604851051},{"date":"2024-02-23","current":-4.544824,"twenty":-21.965452,"median":-6.643088,"eighty":-3.919889,"marketCap":671820499},{"date":"2024-03-01","current":-4.589769,"twenty":-21.899396,"median":-6.601429,"eighty":-3.921051,"marketCap":678464294},{"date":"2024-03-08","current":-4.427968,"twenty":-21.674722,"median":-6.533947,"eighty":-3.921051,"marketCap":654546634},{"date":"2024-03-15","current":-3.860241,"twenty":-21.569116,"median":-6.496851,"eighty":-3.911364,"marketCap":631608711},{"date":"2024-03-22","current":-3.999275,"twenty":-21.509386,"median":-6.463291,"eighty":-3.891167,"marketCap":654357330},{"date":"2024-03-28","current":-3.497116,"twenty":-21.462147,"median":-6.410575,"eighty":-3.874556,"marketCap":572194671},{"date":"2024-04-05","current":-3.484031,"twenty":-21.303045,"median":-6.370546,"eighty":-3.84928,"marketCap":570053625},{"date":"2024-04-12","current":-4.045074,"twenty":-21.147222,"median":-6.326122,"eighty":-3.819153,"marketCap":661850993},{"date":"2024-04-19","current":-3.243584,"twenty":-20.54729,"median":-6.282032,"eighty":-3.800939,"marketCap":530711896},{"date":"2024-04-26","current":-3.150629,"twenty":-17.957202,"median":-6.218346,"eighty":-3.783504,"marketCap":515502812},{"date":"2024-05-03","current":-4.397858,"twenty":-16.774632,"median":-6.186061,"eighty":-3.779629,"marketCap":719573082},{"date":"2024-05-10","current":-4.379492,"twenty":-15.192701,"median":-6.170048,"eighty":-3.779629,"marketCap":716568032},{"date":"2024-05-17","current":-4.260905,"twenty":-14.607181,"median":-6.116483,"eighty":-3.779629,"marketCap":695805862},{"date":"2024-05-24","current":-4.175587,"twenty":-14.349467,"median":-6.09424,"eighty":-3.779629,"marketCap":681873354},{"date":"2024-05-31","current":-3.956436,"twenty":-14.073023,"median":-6.0707,"eighty":-3.779629,"marketCap":646085930},{"date":"2024-06-07","current":-3.999931,"twenty":-13.918938,"median":-6.040581,"eighty":-3.779629,"marketCap":653188778},{"date":"2024-06-14","current":-4.05681,"twenty":-13.616431,"median":-6.014737,"eighty":-3.776092,"marketCap":662477117},{"date":"2024-06-21","current":-3.829294,"twenty":-13.299862,"median":-5.978739,"eighty":-3.772555,"marketCap":625323761},{"date":"2024-06-28","current":-4.14882,"twenty":-13.172486,"median":-5.953176,"eighty":-3.761943,"marketCap":677502371},{"date":"2024-07-05","current":-4.16555,"twenty":-12.915679,"median":-5.936751,"eighty":-3.761943,"marketCap":680234235},{"date":"2024-07-12","current":-5.072268,"twenty":-12.812956,"median":-5.891938,"eighty":-3.761943,"marketCap":828301286},{"date":"2024-07-15","current":-5.035463,"twenty":-12.798187,"median":-5.889829,"eighty":-3.761943,"marketCap":822291184},{"date":"2024-08-02","current":-5.701282,"twenty":-12.400011,"median":-5.833983,"eighty":-3.74922,"marketCap":931019387},{"date":"2024-08-09","current":-5.419995,"twenty":-12.209595,"median":-5.803572,"eighty":-3.74922,"marketCap":922022524},{"date":"2024-08-16","current":-5.760715,"twenty":-12.056579,"median":-5.760163,"eighty":-3.74922,"marketCap":979983964},{"date":"2024-08-23","current":-6.61994,"twenty":-11.988647,"median":-5.760163,"eighty":-3.74922,"marketCap":1126151064},{"date":"2024-08-30","current":-6.500997,"twenty":-11.801336,"median":-5.760163,"eighty":-3.74922,"marketCap":1105917188},{"date":"2024-09-06","current":-6.531177,"twenty":-11.604251,"median":-5.760163,"eighty":-3.74922,"marketCap":1111051157},{"date":"2024-09-13","current":-6.799241,"twenty":-11.52938,"median":-5.760163,"eighty":-3.74922,"marketCap":1156652876},{"date":"2024-09-20","current":-6.662546,"twenty":-11.2786,"median":-5.760163,"eighty":-3.74922,"marketCap":1133399019},{"date":"2024-09-27","current":-5.771366,"twenty":-11.010233,"median":-5.758054,"eighty":-3.74922,"marketCap":981795953},{"date":"2024-10-04","current":-6.218731,"twenty":-10.962393,"median":-5.751729,"eighty":-3.74922,"marketCap":1057899484},{"date":"2024-10-11","current":-5.680828,"twenty":-10.831716,"median":-5.742962,"eighty":-3.74922,"marketCap":966394048},{"date":"2024-10-18","current":-6.24536,"twenty":-10.696822,"median":-5.742962,"eighty":-3.74922,"marketCap":1062429456},{"date":"2024-10-25","current":-5.719884,"twenty":-10.364531,"median":-5.741187,"eighty":-3.74922,"marketCap":973038007},{"date":"2024-10-31","current":-3.937524,"twenty":-10.126279,"median":-5.701282,"eighty":-3.74922,"marketCap":669831874},{"date":"2024-11-08","current":-3.947364,"twenty":-9.863426,"median":-5.683491,"eighty":-3.738421,"marketCap":653912376},{"date":"2024-11-15","current":-3.704901,"twenty":-9.863426,"median":-5.683491,"eighty":-3.75615,"marketCap":613746515},{"date":"2024-11-22","current":-3.888585,"twenty":-9.863426,"median":-5.683491,"eighty":-3.76548,"marketCap":644175197},{"date":"2024-11-29","current":-4.584746,"twenty":-9.863426,"median":-5.683491,"eighty":-3.783674,"marketCap":759499902},{"date":"2024-12-06","current":-4.345957,"twenty":-9.863426,"median":-5.683491,"eighty":-3.783674,"marketCap":719942616},{"date":"2024-12-13","current":-2.75893,"twenty":-9.863426,"median":-5.683491,"eighty":-3.780013,"marketCap":457038803},{"date":"2024-12-20","current":-2.755256,"twenty":-9.863426,"median":-5.683491,"eighty":-3.740305,"marketCap":456430230},{"date":"2024-12-27","current":-2.523815,"twenty":-9.863426,"median":-5.683491,"eighty":-3.726088,"marketCap":418090090},{"date":"2025-01-03","current":-2.454015,"twenty":-9.863426,"median":-5.683491,"eighty":-3.709281,"marketCap":406527191},{"date":"2025-01-10","current":-2.637699,"twenty":-9.863573,"median":-5.686154,"eighty":-3.702138,"marketCap":436955873},{"date":"2025-01-17","current":-2.760767,"twenty":-9.863573,"median":-5.686154,"eighty":-3.695718,"marketCap":457343090},{"date":"2025-01-24","current":-3.054661,"twenty":-9.863573,"median":-5.686154,"eighty":-3.680828,"marketCap":506028981},{"date":"2025-01-31","current":-3.199771,"twenty":-9.863573,"median":-5.686154,"eighty":-3.663153,"marketCap":530067640},{"date":"2025-02-07","current":-2.953635,"twenty":-9.863573,"median":-5.686154,"eighty":-3.638577,"marketCap":489293206},{"date":"2025-02-14","current":-3.543259,"twenty":-9.863573,"median":-5.686154,"eighty":-3.631204,"marketCap":586969275},{"date":"2025-02-21","current":-3.466112,"twenty":-9.863573,"median":-5.686154,"eighty":-3.628522,"marketCap":574189229},{"date":"2025-02-28","current":-3.436115,"twenty":-9.863573,"median":-5.686154,"eighty":-3.624647,"marketCap":499030384},{"date":"2025-03-07","current":-3.463002,"twenty":-9.868611,"median":-5.68837,"eighty":-3.614297,"marketCap":502935208},{"date":"2025-03-14","current":-3.555912,"twenty":-9.868611,"median":-5.68837,"eighty":-3.611055,"marketCap":516428592},{"date":"2025-03-21","current":-3.710057,"twenty":-9.868611,"median":-5.68837,"eighty":-3.600725,"marketCap":538815342},{"date":"2025-03-28","current":-3.938109,"twenty":-9.868611,"median":-5.68837,"eighty":-3.60191,"marketCap":571935465},{"date":"2025-04-02","current":-3.885319,"twenty":-9.868611,"median":-5.68837,"eighty":-3.60191,"marketCap":564268770}],"updateTime":1743687390875}}}